Celldex Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2013
Total Assets: $347.1M
Liabilities Breakdown FY2013
Total Liabilities: $27.3M
Asset Breakdown
Total Assets: $347.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $169.4M | 48.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $10.0M | 2.9% |
| Goodwill | $9.0M | 2.6% |
| Intangible Assets | $22.8M | 6.6% |
| Other Assets | $135.9M | 39.2% |
Liabilities Breakdown
Total Liabilities: $27.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.2M | 8.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $25.1M | 91.8% |